SecSonar.com

Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Virax Biolabs Group Limited (VRAX) is a Biotechnology company based in GB with a market capitalization of $769K. Revenue declined 96.0% year-over-year and free cash flow was negative at -$5.2M. This page tracks VRAX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 17 employees · IPO Jul 21, 2022

Valuation

Valuation & price

$0.15 · as of May 17, 2026 · -99.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$27.75$15.43$3.11Jul 25Dec 25Jul 26Jul 7, 25$21.50Jul 9, 25$23.09Jul 11, 25$22.50Jul 15, 25$21.75Jul 17, 25$23.00Jul 21, 25$27.75Jul 23, 25$24.89Jul 25, 25$24.72Jul 29, 25$23.17Jul 31, 25$20.25Aug 4, 25$20.75Aug 6, 25$19.63Aug 11, 25$19.00Aug 13, 25$18.76Aug 15, 25$19.37Aug 19, 25$19.38Aug 21, 25$18.53Aug 25, 25$19.35Aug 27, 25$14.87Aug 29, 25$15.15Sep 3, 25$15.11Sep 5, 25$14.12Sep 9, 25$14.61Sep 11, 25$14.50Sep 16, 25$15.75Sep 18, 25$16.10Sep 22, 25$15.50Sep 24, 25$15.93Sep 26, 25$15.33Sep 30, 25$15.20Oct 2, 25$15.27Oct 6, 25$15.72Oct 8, 25$17.06Oct 10, 25$16.31Oct 14, 25$16.52Oct 16, 25$15.38Oct 21, 25$16.00Oct 23, 25$14.75Oct 27, 25$14.60Oct 29, 25$14.94Oct 31, 25$14.05Nov 4, 25$12.75Nov 6, 25$12.51Nov 10, 25$11.58Nov 12, 25$11.53Nov 14, 25$12.28Nov 18, 25$11.27Nov 20, 25$10.05Nov 25, 25$10.13Nov 28, 25$10.07Dec 2, 25$9.82Dec 4, 25$16.10Dec 8, 25$13.23Dec 10, 25$12.23Dec 12, 25$11.35Dec 16, 25$9.95Dec 18, 25$9.65Dec 22, 25$9.63Dec 24, 25$9.25Dec 29, 25$8.21Jan 2, 26$9.60Jan 6, 26$10.53Jan 8, 26$9.20Jan 12, 26$8.55Jan 14, 26$8.33Jan 16, 26$7.65Jan 21, 26$6.83Jan 23, 26$6.58Jan 27, 26$7.00Jan 29, 26$7.12Feb 2, 26$6.80Feb 4, 26$6.20Feb 9, 26$5.76Feb 11, 26$5.43Feb 13, 26$5.17Feb 18, 26$5.45Feb 20, 26$5.33Feb 24, 26$5.34Feb 26, 26$5.53Mar 2, 26$5.51Mar 4, 26$5.23Mar 6, 26$5.36Mar 10, 26$5.07Mar 12, 26$4.90Mar 17, 26$5.07Mar 19, 26$4.54Mar 23, 26$4.41Mar 25, 26$4.63Mar 27, 26$3.98Mar 31, 26$5.50Apr 2, 26$4.35Apr 7, 26$3.50Apr 9, 26$3.37Apr 13, 26$4.16Apr 15, 26$3.89Apr 17, 26$3.75Apr 22, 26$3.38Apr 24, 26$3.99Apr 28, 26$3.35Apr 30, 26$3.35May 4, 26$3.28May 6, 26$3.15May 8, 26$4.28May 12, 26$3.62May 14, 26$3.50May 18, 26$5.88May 20, 26$7.98May 22, 26$6.94May 28, 26$5.29Jun 1, 26$4.47Jun 3, 26$6.00Jun 5, 26$5.31Jun 9, 26$4.71Jun 11, 26$4.56Jun 15, 26$4.32Jun 17, 26$4.23Jun 22, 26$4.08Jun 24, 26$3.30Jun 26, 26$3.11Jul 2, 26$3.13
$2.6052-week range$27.75
Loading valuation history…

Fundamentals

Key fundamentals

$769K

Market cap

-96.0%

Revenue growth (YoY)

-838.2%

Gross margin

-$5.2M

Free cash flow (USD)

-$3.9M

Net debt

Net cash position

54.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$99.9KFY 2021$123.8KFY 2022$0.00FY 2023$8.6KFY 2024$156.4KFY 2025$6.3K
$99.9K$6.3K

Free cash flow by year

2020 → 2025

FY 2020$-744.6KFY 2021$-590.2KFY 2022$-809.1KFY 2023$-4.4MFY 2024$-7.4MFY 2025$-5.2M
-$744.6K-$5.2M

Gross margin by year

2021 → 2025

FY 2021-7.6%FY 2023-15.9%FY 202432.3%FY 2025-838.2%
-7.6%-838.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 3, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingShare ConsolidationJun 24, 2026Filing
  • Annual reportAnnual Report FiledJun 12, 2026Filing
  • 6-K filingPositive Clinical Data ReportMay 26, 2026Filing
  • 6-K filingAmended Memorandum and ArticlesMay 22, 2026Filing
  • 6-K filingShareholder LetterApr 14, 2026Filing
  • 6-K filingUnregistered Sale of Equity SecuritiesApr 10, 2026Filing

Questions

Frequently asked questions

What is Virax Biolabs Group Limited's market cap?

Virax Biolabs Group Limited (VRAX) has a market capitalization of $769K.

What is VRAX's P/E ratio?

A meaningful P/E ratio is not available for VRAX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VRAX's price-to-book (P/B) ratio?

VRAX trades at 0.13 times book value per share.

When did Virax Biolabs Group Limited last report earnings?

VRAX last reported earnings on June 3, 2026; the next date is not yet scheduled.

Are insiders buying VRAX stock?

SEC Form 4 filings show no open-market insider buys at Virax Biolabs Group Limited in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ASBP

Aspire Biopharma Holdings, Inc.

$627.6K

SCNI

Scinai Immunotherapeutics Ltd.

$604.8K

BDRX

Biodexa Pharmaceuticals Plc

$573.7K

SPRC

SciSparc Ltd.

$523.4K

NEXR

Nexera Technologies Ltd

$1M

ONCO

Onconetix, Inc.

$400.8K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.